4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine

C102H79F18N35O13S6 — CID 158998894

IUPAC4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine
SMILESCS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCNCC3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)ncnc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(c2)CNC3=O)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3nc(N)ccc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc3ccccn23)c1-c1nn[nH]n1.Cc1ccncc1-c1ccc(C(F)(F)F)c(S(C)(=O)=O)c1-c1nn[nH]n1
InChIInChI=1S/C19H19F3N6O2S.C18H13F3N6O2S.C17H12F3N7O2S.C17H12F3N5O3S.C16H11F3N6O2S.C15H12F3N5O2S/c1-31(29,30)17-14(19(20,21)22)4-3-13(16(17)18-25-27-28-26-18)12-2-5-15(24-10-12)11-6-8-23-9-7-11;1-30(28,29)16-12(18(19,20)21)5-4-11(15(16)17-24-26-27-25-17)9-2-6-13-10(8-9)3-7-14(22)23-13;1-30(28,29)14-11(17(18,19)20)5-4-9(13(14)16-24-26-27-25-16)8-2-3-10-12(6-8)22-7-23-15(10)21;1-29(27,28)14-12(17(18,19)20)5-4-10(13(14)15-22-24-25-23-15)8-2-3-11-9(6-8)7-21-16(11)26;1-28(26,27)14-10(16(17,18)19)6-5-9(13(14)15-21-23-24-22-15)11-8-20-12-4-2-3-7-25(11)12;1-8-5-6-19-7-10(8)9-3-4-11(15(16,17)18)13(26(2,24)25)12(9)14-20-22-23-21-14/h2-5,10-11,23H,6-9H2,1H3,(H,25,26,27,28);2-8H,1H3,(H2,22,23)(H,24,25,26,27);2-7H,1H3,(H2,21,22,23)(H,24,25,26,27);2-6H,7H2,1H3,(H,21,26)(H,22,23,24,25);2-8H,1H3,(H,21,22,23,24);3-7H,1-2H3,(H,20,21,22,23)
InChIKeyJRCBKNVIRKHIBO-UHFFFAOYSA-N
MW2537.35 g/mol
LogP15.85
Rot. Bonds19

About 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine

4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine (PubChem CID 158998894) has the molecular formula C102H79F18N35O13S6 and a molecular weight of 2537.35 g/mol. Its IUPAC name is 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine.

Molecular Properties

Compound Name4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine
PubChem CID158998894
Molecular FormulaC102H79F18N35O13S6
Molecular Weight2537.35 g/mol
Exact Mass2535.46
IUPAC Name4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine
SMILESCS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCNCC3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)ncnc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(c2)CNC3=O)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3nc(N)ccc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc3ccccn23)c1-c1nn[nH]n1.Cc1ccncc1-c1ccc(C(F)(F)F)c(S(C)(=O)=O)c1-c1nn[nH]n1
InChIInChI=1S/C19H19F3N6O2S.C18H13F3N6O2S.C17H12F3N7O2S.C17H12F3N5O3S.C16H11F3N6O2S.C15H12F3N5O2S/c1-31(29,30)17-14(19(20,21)22)4-3-13(16(17)18-25-27-28-26-18)12-2-5-15(24-10-12)11-6-8-23-9-7-11;1-30(28,29)16-12(18(19,20)21)5-4-11(15(16)17-24-26-27-25-17)9-2-6-13-10(8-9)3-7-14(22)23-13;1-30(28,29)14-11(17(18,19)20)5-4-9(13(14)16-24-26-27-25-16)8-2-3-10-12(6-8)22-7-23-15(10)21;1-29(27,28)14-12(17(18,19)20)5-4-10(13(14)15-22-24-25-23-15)8-2-3-11-9(6-8)7-21-16(11)26;1-28(26,27)14-10(16(17,18)19)6-5-9(13(14)15-21-23-24-22-15)11-8-20-12-4-2-3-7-25(11)12;1-8-5-6-19-7-10(8)9-3-4-11(15(16,17)18)13(26(2,24)25)12(9)14-20-22-23-21-14/h2-5,10-11,23H,6-9H2,1H3,(H,25,26,27,28);2-8H,1H3,(H2,22,23)(H,24,25,26,27);2-7H,1H3,(H2,21,22,23)(H,24,25,26,27);2-6H,7H2,1H3,(H,21,26)(H,22,23,24,25);2-8H,1H3,(H,21,22,23,24);3-7H,1-2H3,(H,20,21,22,23)
InChIKeyJRCBKNVIRKHIBO-UHFFFAOYSA-N
XLogP15.85
TPSA706.52 Ų
H-Bond Donors10
H-Bond Acceptors41
Rotatable Bonds19
Heavy Atoms174
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002537.35
LogP ≤ 515.85
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1041

Analyze 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine?
The IUPAC name of 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine (CID 158998894) is 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine.
What is the SMILES notation for 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine?
The canonical SMILES for 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine is CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCNCC3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(N)ncnc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3c(c2)CNC3=O)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3nc(N)ccc3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc3ccccn23)c1-c1nn[nH]n1.Cc1ccncc1-c1ccc(C(F)(F)F)c(S(C)(=O)=O)c1-c1nn[nH]n1.
What is the InChIKey of 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine?
The InChIKey is JRCBKNVIRKHIBO-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H19F3N6O2S.C18H13F3N6O2S.C17H12F3N7O2S.C17H12F3N5O3S.C16H11F3N6O2S.C15H12F3N5O2S/c1-31(29,30)17-14(19(20,21)22)4-3-13(16(17)18-25-27-28-26-18)12-2-5-15(24-10-12)11-6-8-23-9-7-11;1-30(28,29)16-12(18(19,20)21)5-4-11(15(16)17-24-26-27-25-17)9-2-6-13-10(8-9)3-7-14(22)23-13;1-30(28,29)14-11(17(18,19)20)5-4-9(13(14)16-24-26-27-25-16)8-2-3-10-12(6-8)22-7-23-15(10)21;1-29(27,28)14-12(17(18,19)20)5-4-10(13(14)15-22-24-25-23-15)8-2-3-11-9(6-8)7-21-16(11)26;1-28(26,27)14-10(16(17,18)19)6-5-9(13(14)15-21-23-24-22-15)11-8-20-12-4-2-3-7-25(11)12;1-8-5-6-19-7-10(8)9-3-4-11(15(16,17)18)13(26(2,24)25)12(9)14-20-22-23-21-14/h2-5,10-11,23H,6-9H2,1H3,(H,25,26,27,28);2-8H,1H3,(H2,22,23)(H,24,25,26,27);2-7H,1H3,(H2,21,22,23)(H,24,25,26,27);2-6H,7H2,1H3,(H,21,26)(H,22,23,24,25);2-8H,1H3,(H,21,22,23,24);3-7H,1-2H3,(H,20,21,22,23).
What are the key properties of 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine?
4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine has a molecular weight of 2537.35 g/mol, XLogP of 15.85, 19 rotatable bonds, 10 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methyl-3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,3-dihydroisoindol-1-one;3-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2-piperidin-4-ylpyridine;7-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinazolin-4-amine;6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]quinolin-2-amine is sourced from PubChem (CID 158998894), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).